Previous business/academic article Next business/academic article
Soft law > Intellectual Property

Study on Free Market and Competition in the Expired-Patent Drug Markets in Mexico

Federal Economic Competition Commission (COFECE), Study, August 2017

See Mexico's Federal Commission for Economic Competition's resume

Vote for this articleHelp

* Average
** Interesting
*** Good
**** Excellent
***** Must receive an Award!

Please note that the star(s) appearing on the article page before you have voted reflect the status of all votes registered to date.

Readers’ vote will close on February 9, 2018. Readers’ vote will allow you to nominate 1 article for each of the Awards, i.e., 10 Academic articles, 10 Business articles, and the best Soft Laws. The readers’ short-list of Academic and Business Articles will be communicated to the Board together with the 20 articles nominated by the Steering Committees. The Board will decide on the award-winning articles. Results will be announced at the Awards ceremony to take place in Washington DC on the eve of the ABA Antitrust Spring Meeting on April 10, 2018.

Click here to read the full article online

In July 2016, COFECE’s board of Commissioners ordered the development of a Market study to detect competition concerns in the off-patent drug market derived from regulatory and public policy failures.

In August 2017, the Commission published the “Study on free market and competition in the expired-patent drug markets in Mexico” which finds competition problems that hamper the participation of a greater number of economic agents in the market and in consequence, the incentives to ensure more options of drugs at competitive prices for Mexican families.